Of mice and men, MMXXI: Anaphylaxis - 05/01/22
Doi : 10.1016/j.jaci.2021.08.029
Thomas A.E. Platts-Mills, MD, PhD ⁎ 
, Ryan C. Eid, MD, Behnam Keshavarz, PhD
, Ryan C. Eid, MD, Behnam Keshavarz, PhD Division of Allergy and Clinical Immunology, Department of Medicine, University of Virginia, Charlottesville, Va
∗Corresponding author: Thomas A. E. Platts-Mills, MD, PhD, Division of Allergy and Clinical Immunology, University of Virginia, PO Box 801355, Charlottesville, VA 22908-1355.Division of Allergy and Clinical ImmunologyUniversity of VirginiaPO Box 801355CharlottesvilleVA22908-1355
Key words : Food allergy, allergic disease, alpha-gal, gastrointestinal absorption
Le texte complet de cet article est disponible en PDF.
| Supported by the National Institutes of Health (grant NIH R37 AI20565 [to T.A.E.P.-M.]). |
|
| Disclosure of potential conflict of interest: T. A. E. Platts-Mills has received assay support from Thermo Fisher Scientific. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2021
Publié par Elsevier Masson SAS.
Vol 149 - N° 1
P. 58-59 - janvier 2022 Retour au numéro
Article précédent
- Transcriptomic drug-response gene signatures are informative for the stratification of patients for clinical trials
- Paul S. Foster, Jessica L. Barnes, Hock L. Tay, Peter G. Gibson
- Immune checkpoint molecules on ILC2s as potential therapeutic targets for allergic diseases
- Hideaki Morita, Hirohisa Saito, Kenji Matsumoto
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?